Search results
Results From The WOW.Com Content Network
Cellular immunity, also known as cell-mediated immunity, is an immune response that does not rely on the production of antibodies. Rather, cell-mediated immunity is the activation of phagocytes , antigen-specific cytotoxic T-lymphocytes , and the release of various cytokines in response to an antigen .
These antibodies can cause antibody-mediated rejection and are therefore considered a contraindication against transplantation in most cases. [1] DSA are a result of B cell and plasma cell activation and bind to HLA and/or non-HLA molecules on the endothelium [ 1 ] of the graft.
Transplant glomerulopathy is considered a form of chronic antibody-mediated rejection. PAS stain. Chronic rejection is an insidious form of rejection that leads to graft destruction over the course of months, but most often years after tissue transplantation. [12]
Antibody-dependent cellular cytotoxicity (ADCC), also referred to as antibody-dependent cell-mediated cytotoxicity, is a mechanism of cell-mediated immune defense whereby an effector cell of the immune system kills a target cell, whose membrane-surface antigens have been bound by specific antibodies. [1]
Positive selection is based on steady cross-talk between T FH cells and their cognate antigen presenting GC B cell. Because a limited number of T FH cells reside in the germinal center, only highly competitive B cells stably conjugate with T FH cells and thus receive T cell-dependent survival signals. B cell progeny that have undergone SHM, but ...
Humoral immunity is also referred to as antibody-mediated immunity. The study of the molecular and cellular components that form the immune system , including their function and interaction, is the central science of immunology .
In central tolerance, dendritic cells are present within the thymus, or the location of T cell development and maturation. Thymic dendritic cells can intake dead medullary thymic epithelial cells, and cross present "self" peptides on MHC class I as a negative selection check on cytotoxic T cells that have a high affinity for self peptides. [6]
Selection of specific adjuvants or types varies depending upon whether they are to be used for research and antibody production or in vaccine development. Adjuvants for vaccine use only need to produce protective antibodies and good systemic memory while those for antiserum production need to rapidly induce high titer, high avidity antibodies.